Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 48.80M | 48.67M | 51.87M | 56.97M | 53.90M | 36.35M |
Gross Profit | 20.02M | 19.50M | 21.81M | 25.37M | 22.83M | 15.56M |
EBITDA | -4.22M | -6.88M | -7.97M | -6.10M | -6.73M | -6.08M |
Net Income | -7.13M | -8.91M | -9.57M | -7.55M | -5.22M | -6.33M |
Balance Sheet | ||||||
Total Assets | 34.24M | 29.14M | 34.44M | 42.29M | 48.69M | 27.97M |
Cash, Cash Equivalents and Short-Term Investments | 7.24M | 2.39M | 7.03M | 13.92M | 23.85M | 11.63M |
Total Debt | 1.66M | 4.64M | 2.75M | 1.77M | 2.66M | 4.19M |
Total Liabilities | 27.38M | 27.04M | 24.91M | 25.06M | 25.39M | 10.60M |
Stockholders Equity | 852.00K | 2.10M | 9.52M | 17.23M | 23.30M | 17.37M |
Cash Flow | ||||||
Free Cash Flow | -6.79M | -7.30M | -6.85M | -9.80M | 8.00M | -3.33M |
Operating Cash Flow | -6.79M | -7.29M | -6.75M | -9.52M | 8.22M | -3.24M |
Investing Cash Flow | -21.00K | -13.00K | -109.00K | -286.00K | -5.56M | -93.00K |
Financing Cash Flow | 8.64M | 2.60M | -5.00K | -73.00K | 9.47M | 2.47M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
52 Neutral | $7.45B | 0.27 | -61.87% | 2.30% | 16.62% | 1.04% | |
51 Neutral | $25.38M | ― | -329.16% | ― | 2115.38% | -4.40% | |
47 Neutral | $15.95M | ― | -194.33% | ― | -2.24% | 36.09% | |
43 Neutral | $10.34M | ― | -93.11% | ― | 85.24% | -27.93% | |
37 Underperform | $131.09K | ― | ― | -2.99% | 59.87% | ||
35 Underperform | $39.45M | ― | -196.69% | ― | ― | ― | |
34 Underperform | $315.25M | ― | 5400.35% | ― | 122.22% | 79.08% |
On June 11, 2025, Iridex Corporation held its Annual Meeting of Stockholders at its headquarters in Mountain View, California, where several key proposals were approved. Notably, the stockholders approved an amendment to the 2008 Equity Incentive Plan, increasing the shares reserved for issuance and extending the plan’s term. Additionally, the appointment of BPM LLP as the independent registered public accounting firm was ratified, and various governance-related proposals were passed, including the election of directors and amendments to the company’s charter. These decisions reflect a strategic effort to enhance corporate governance and operational flexibility, potentially impacting the company’s future growth and shareholder value.
On May 20, 2025, IRIDEX Corporation amended its Investor Rights Agreement with Novel Inspiration International Co., Ltd. The amendment restricts the company from disposing of a substantial portion of its assets without unanimous board approval, unless the transaction involves a wholly-owned subsidiary.
On May 14, 2025, Iridex Corporation received a notification from Nasdaq regarding non-compliance with the minimum stockholders’ equity requirement for continued listing, as their equity was reported at approximately $852,000, below the $2,500,000 threshold. The company plans to address this by seeking stockholder approval to amend its charter, which would reclassify its Series B Preferred Stock as permanent equity, potentially regaining compliance. The notice does not immediately impact the listing of Iridex’s common stock, and the company is exploring additional options to meet Nasdaq’s requirements.